PI
KERX

Placemark Investments’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Placemark Investments’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$144K Sell
10,199
-445
-4% -$6.9K ﹤0.01% 1585
2014
Q3 		$146K Buy
+10,644
New +$163K ﹤0.01% 1594

Other funds holding KERX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Placemark Investments's KERX Position: Q4 2014 in Review

Placemark Investments reduced its Keryx Biopharmaceuticals Inc (KERX) stake by 4.2% in Q4 2014, selling an estimated $6.9K and leaving 10,199 shares worth $144K. The position accounts for ﹤0.01% of the portfolio, ranked #1585.

Placemark Investments first reported a position in KERX in Q3 2014 and has held it in 2 quarters since. The position peaked at $146K in Q3 2014. 147 funds tracked by Wall St. Rank hold KERX as of Q4 2014.

  • Placemark Investments held 10,199 shares of Keryx Biopharmaceuticals Inc worth $144K as of Q4 2014.
  • Placemark Investments sold 445 Keryx Biopharmaceuticals Inc shares in Q4 2014, an estimated $6.9K.
  • Keryx Biopharmaceuticals Inc made up ﹤0.01% of Placemark Investments's portfolio in Q4 2014, its #1585 holding.
  • Placemark Investments first reported a position in Keryx Biopharmaceuticals Inc in Q3 2014 and has held it in 2 quarters since.
  • Placemark Investments's Keryx Biopharmaceuticals Inc position peaked at $146K in Q3 2014.
  • 147 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2014.

Based on Placemark Investments's 13F filing for Q4 2014, filed 17 Feb 2015.